Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 16/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 16/20 | 0.52 |
| ▸ | F2R | P25116 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7444745 | 0.92 | ITGB3 (0.61) | ITGB3ITGA2BF2R | |
| SCHEMBL7501692 | 0.91 | ITGB3 (0.63) | ITGB3ITGA2BF2RALDH1A1L3MBTL1 | |
| SCHEMBL7504283 | 0.91 | ITGB3 (0.54) | ITGB3ITGA2BF2RALDH1A1L3MBTL1 | |
| SCHEMBL6942125 | 0.88 | ITGB3 (0.55) | ITGB3ITGA2BF2RALDH1A1L3MBTL1 | |
| SCHEMBL6936057 | 0.88 | ITGB3 (0.55) | ITGB3ITGA2BF2RALDH1A1L3MBTL1 | |
| SCHEMBL7450062 | 0.87 | L3MBTL1 (0.42) | ITGB3ITGA2BL3MBTL1 | |
| SCHEMBL7446958 | 0.86 | KDM4E (0.52) | ITGB3ITGA2BF2R | |
| SCHEMBL7506215 | 0.85 | ITGB3 (0.50) | ITGB3ITGA2BF2R | |
| SCHEMBL7503248 | 0.85 | ITGB3 (0.62) | ITGB3ITGA2BF2R | |
| SCHEMBL7502459 | 0.85 | ITGB3 (0.52) | ITGB3ITGA2BF2RALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-0869944-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | disclosed |